These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 8618345
21. Bladder squamous cell carcinoma biomarkers derived from proteomics. Celis JE, Wolf H, Ostergaard M. Electrophoresis; 2000 Jun; 21(11):2115-21. PubMed ID: 10892722 [Abstract] [Full Text] [Related]
22. [Expression of bcl-2 and p16 in transitional cell carcinoma of urinary bladder]. Leng J, Zhang Y, Yao X, Wen K. Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):40-3. PubMed ID: 11831985 [Abstract] [Full Text] [Related]
23. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker. Nouraee N, Mowla SJ, Ozhand A, Parvin M, Ziaee SA, Hatefi N. Urol J; 2009 Jan; 6(2):101-8. PubMed ID: 19472128 [Abstract] [Full Text] [Related]
24. Short-term culturing of low-grade superficial bladder transitional cell carcinomas leads to changes in the expression levels of several proteins involved in key cellular activities. Celis A, Rasmussen HH, Celis P, Basse B, Lauridsen JB, Ratz G, Hein B, Ostergaard M, Wolf H, Orntoft T, Celis JE. Electrophoresis; 1999 Feb; 20(2):355-61. PubMed ID: 10197443 [Abstract] [Full Text] [Related]
25. Tumor-derived hyaluronidase: a diagnostic urine marker for high-grade bladder cancer. Pham HT, Block NL, Lokeshwar VB. Cancer Res; 1997 Feb 15; 57(4):778-83. PubMed ID: 9044860 [Abstract] [Full Text] [Related]
26. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains. Tamas EF, Epstein JI. Am J Surg Pathol; 2007 Mar 15; 31(3):390-7. PubMed ID: 17325480 [Abstract] [Full Text] [Related]
27. Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation. Wu RL, Osman I, Wu XR, Lu ML, Zhang ZF, Liang FX, Hamza R, Scher H, Cordon-Cardo C, Sun TT. Cancer Res; 1998 Mar 15; 58(6):1291-7. PubMed ID: 9515818 [Abstract] [Full Text] [Related]
28. [Correlation of clusterin expression to prognosis of bladder carcinoma]. Luo JH, Xie D, Chen W, Dai YP, Li XF, Tao Y, Zheng KL. Ai Zheng; 2005 Jun 15; 24(6):743-7. PubMed ID: 15946493 [Abstract] [Full Text] [Related]
33. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2. Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M. J Urol; 2001 May 15; 165(5):1481-7. PubMed ID: 11342901 [Abstract] [Full Text] [Related]
34. Overexpression of annexin a1 induced by terephthalic acid calculi in rat bladder cancer. Cui L, Wang Y, Shi Y, Zhang Z, Xia Y, Sun H, Wang S, Chen J, Zhang W, Lu Q, Song L, Wei Q, Zhang R, Wang X. Proteomics; 2007 Nov 15; 7(22):4192-202. PubMed ID: 17994624 [Abstract] [Full Text] [Related]
37. Psoriasin expression in mammary epithelial cells in vitro and in vivo. Enerbäck C, Porter DA, Seth P, Sgroi D, Gaudet J, Weremowicz S, Morton CC, Schnitt S, Pitts RL, Stampl J, Barnhart K, Polyak K. Cancer Res; 2002 Jan 01; 62(1):43-7. PubMed ID: 11782356 [Abstract] [Full Text] [Related]
38. Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy. Leach FS, Hsieh JT, Molberg K, Saboorian MH, McConnell JD, Sagalowsky AI. Cancer; 2000 May 15; 88(10):2333-41. PubMed ID: 10820356 [Abstract] [Full Text] [Related]
39. Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients. Bae SM, Lee CH, Cho YL, Nam KH, Kim YW, Kim CK, Han BD, Lee YJ, Chun HJ, Ahn WS. Gynecol Oncol; 2005 Oct 15; 99(1):26-35. PubMed ID: 16051329 [Abstract] [Full Text] [Related]